Trial Profile
Phase 2 study of CMB305 in patients with tumours
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 17 Dec 2014
Price :
$35
*
At a glance
- Drugs CMB 305 (Primary)
- Indications Cancer
- Focus Therapeutic Use
- Sponsors Immune Design
- 17 Dec 2014 New trial record
- 13 Nov 2014 According to an Immune Design media release, this is one of the two phase 2 studies and it is intended to begin in the latter part of 2015.